Mercury Systems Receives Small Business Award from Lockheed Martin
Jun 13, 2017 20:15 pm UTC| Business
ANDOVER, Mass., June 13, 2017 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com), announced it recently received a 2016 Small Business Award from Lockheed Martin’s Missiles and Fire Control business unit at a...
EnerSys Announces $60M in New Global Space Business
Jun 13, 2017 20:15 pm UTC| Business
READING, Pa., June 13, 2017 -- EnerSys (NYSE:ENS), the global leader in stored energy solutions for industrial applications, has recently been selected to supply lithium-ion cells and batteries valued at over $60...
FXCM Group Reports Monthly Metrics
Jun 13, 2017 20:15 pm UTC| Business
NEW YORK, June 13, 2017 -- FXCM Group, LLC ("FXCM Group" or “FXCM”), a leading international provider of online foreign exchange trading, CFD trading, spread betting and related services, today announced certain key...
Associa Gulf Coast Hosts Hurricane Preparedness Seminar
Jun 13, 2017 20:11 pm UTC| Business
Fort Myers, FL, June 13, 2017 -- Associa Gulf Coast (AGC) will be hosting a hurricane preparedness seminar for community managers and homeowners who are located in potential hurricane-affected areas. The seminar will be...
Fox Factory Holding Corp. Announces Appointment of Elizabeth A. Fetter to Board of Directors
Jun 13, 2017 20:05 pm UTC| Business
SCOTTS VALLEY, Calif., June 13, 2017 -- Fox Factory Holding Corp. (NASDAQ:FOXF) ("FOX" or the “Company”) today announced the appointment of Elizabeth A. Fetter as a director on its Board of Directors, effective...
Zafgen to Present at the JMP Securities Life Sciences Conference
Jun 13, 2017 20:05 pm UTC| Business
BOSTON, June 13, 2017 -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases including type 2 diabetes and...
Ovid Therapeutics Reports First Quarter 2017 Financial Results and Recent Corporate Progress
Jun 13, 2017 20:05 pm UTC| Business
Completed Initial Public Offering Raising $75 Million in Gross Proceeds Initiated Phase 2 STARS Clinical Trial of OV101 in Adults with Angelman Syndrome Entered into Innovative Global Collaboration with Takeda Focused...